COVID-19 trials registries data warehouse

http://en.irct.ir/trial/51364

gholamreza khamisipour

Research@Bpums.Ac.Ir

2020-10-11

Completed

RCT

Randomized

Parallel

Blind label

single-center

Treatment

Confirmation of Covid 19 The patient's clinical condition confirms the indication for hospitalization. Chest CT scan shows more than 25% of pulmonary involvement. SPO2 equal to or less than 94% on the day of admission Hemoglobin should be less than 12 g / dl (women) and less than 13 g / dl (men) on the day of admission. Absence of absolute or partial contraindications including history of allergies, anaphylaxis, history of thrombosis, pregnancy Satisfaction of the patient or his/her legal companions to participate in the study

Contraindications for receiving blood. The patient's unwillingness to receive blood. The need to receive blood as a treatment in the course of the disease for other reasons.

2

Boushehr University of Medical Sciences

18

100

Iran

Moderate/severe disease at enrollment

4: Moderate/severe disease at enrollment

40

Blood oxygen saturation

Not reported

[{"arm_notes": "", "treatment_id": 216, "treatment_name": "Blood transfusion", "treatment_type": "Advanced therapy medicinal products (atmp)", "pharmacological_treatment": "Biological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]